BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27258812)

  • 1. Assessment of CTLA-4 Deficiency-Related Autoimmune Choroidopathy Response to Abatacept.
    Shields CL; Say EA; Mashayekhi A; Garg SJ; Dunn JP; Shields JA
    JAMA Ophthalmol; 2016 Jul; 134(7):844-6. PubMed ID: 27258812
    [No Abstract]   [Full Text] [Related]  

  • 2. Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4.
    Lee S; Moon JS; Lee CR; Kim HE; Baek SM; Hwang S; Kang GH; Seo JK; Shin CH; Kang HJ; Ko JS; Park SG; Choi M
    J Allergy Clin Immunol; 2016 Jan; 137(1):327-330. PubMed ID: 26478010
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Intracerebral Lesions with Abatacept in a CTLA4-Haploinsufficient Patient.
    van Leeuwen EM; Cuadrado E; Gerrits AM; Witteveen E; de Bree GJ
    J Clin Immunol; 2018 May; 38(4):464-467. PubMed ID: 29796761
    [No Abstract]   [Full Text] [Related]  

  • 4. From bedside to the bench: uncovering the role of a T-cell protein in protecting CTLA-4.
    Nussbaum G
    Oral Dis; 2016 May; 22(4):249-50. PubMed ID: 26847262
    [No Abstract]   [Full Text] [Related]  

  • 5. IMMUNOLOGY. Moving CTLA-4 from the trash to recycling.
    Sansom DM
    Science; 2015 Jul; 349(6246):377-8. PubMed ID: 26206917
    [No Abstract]   [Full Text] [Related]  

  • 6. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
    Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
    Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Presentations of LRBA Deficiency: a Single-Center Experience.
    Kostel Bal S; Haskologlu S; Serwas NK; Islamoglu C; Aytekin C; Kendirli T; Kuloglu Z; Yavuz G; Dalgic B; Siklar Z; Kansu A; Ensari A; Boztug K; Dogu F; Ikinciogullari A
    J Clin Immunol; 2017 Nov; 37(8):790-800. PubMed ID: 28956255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency.
    Lanz AL; Riester M; Peters P; Schwerd T; Lurz E; Hajji MS; Rohlfs M; Ley-Zaporozhan J; Walz C; Kotlarz D; Klein C; Albert MH; Hauck F
    Clin Immunol; 2021 Aug; 229():108779. PubMed ID: 34116213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with Abatacept.
    Angelino G; Cifaldi C; Zangari P; Di Cesare S; Di Matteo G; Chiriaco M; Francalanci P; Faraci S; Rea F; Romeo EF; Amodio D; Ursu GM; Bertocchini A; Accinni A; Crocoli A; Inserra A; Cozza R; Romano C; Licciardello M; Rinelli M; Dall'Oglio L; Cancrini C; De Angelis P; Finocchi A
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1051-e1056. PubMed ID: 34034269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Granulomatosis and primary immunodeficiency in adulthood].
    Pavic M; Pasquet F; Fieschi C; Malphettes M; Sève P
    Rev Med Interne; 2013 Mar; 34(3):154-8. PubMed ID: 22425132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects.
    Dhunputh C; Ducassou S; Fernandes H; Picard C; Rieux-Laucat F; Viallard JF; Lazaro E; Hermine O; Jouvray M; Machelard I; Lambilliotte A; Malphettes M; Moshous D; Neven B; Gauthier A; Garnier N; Leblanc T; Landman-Parker J; Leverger G; Aladjidi N
    Blood; 2022 Jan; 139(2):300-304. PubMed ID: 34714911
    [No Abstract]   [Full Text] [Related]  

  • 12. Follow-up of lupus choroidopathy with optical coherence tomography.
    Ozturk B; Bozkurt B; Karademir Z; Kerimoglu H
    Lupus; 2011 Oct; 20(10):1076-8. PubMed ID: 21562018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual Late-onset Enteropathy in a Patient With Lipopolysaccharide-responsive Beige-like Anchor Protein Deficiency.
    Maggiore R; Grossi A; Fioredda F; Palmisani E; Terranova P; Cappelli E; Lanza T; Pierri F; Guardo D; Calvillo M; Micalizzi C; Beccaria A; Coccia MC; Arrigo S; Dufour C; Ceccherini I; Miano M
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):e768-e771. PubMed ID: 31876783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An 18-year-old woman with pulmonary nodules found to have cytotoxic T-lymphocyte-associated antigen 4 deficiency.
    Al Baroudi S; Collaco JM; McGrath-Morrow S
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31818888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OCT follow-up of systemic lupus erythematosus choroidopathy.
    Kouprianoff S; Chiquet C; Bouillet L; Romanet JP
    Ocul Immunol Inflamm; 2010 Apr; 18(2):113-5. PubMed ID: 20370340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A de novo monoallelic CTLA-4 deletion causing pediatric onset CVID with recurrent autoimmune cytopenias and severe enteropathy.
    Lougaris V; Baronio M; Gazzurelli L; Lorenzini T; Fuoti M; Moratto D; Bozzola A; Ricci C; Bondioni MP; Ravelli A; Villanacci V; Plebani A
    Clin Immunol; 2018 Dec; 197():186-188. PubMed ID: 30326257
    [No Abstract]   [Full Text] [Related]  

  • 17. Choroidal Infiltrate of Unknown Cause.
    McKay KM; Sobrin L
    JAMA Ophthalmol; 2019 Feb; 137(2):222-223. PubMed ID: 30543336
    [No Abstract]   [Full Text] [Related]  

  • 18. Asymptomatic choroidal granulomas in common variable immunodeficiency.
    Kashani S; Gazzard G; Jolles S; Larkin G
    Clin Exp Ophthalmol; 2005 Dec; 33(6):663-4. PubMed ID: 16402965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidopathy associated with AIDS.
    Silva RA; Castresana D; Davis JE
    JAMA Ophthalmol; 2013 Sep; 131(9):1235-8. PubMed ID: 23846507
    [No Abstract]   [Full Text] [Related]  

  • 20. An appraisal of T cell subsets and the potential for autoimmune injury.
    Kelly CJ; Frishberg Y; Gold DP
    Kidney Int; 1998 Jun; 53(6):1574-84. PubMed ID: 9607187
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.